21-valent pneumococcal vaccine
Scope
Date
~
-
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Business & Politics
Jay Y. Lee meets Verizon CEO and Moderna co-founder
Samsung Electronics Co. Vice Chairman Jay Y. Lee has met with biopharmaceutical conglomerate Moderna’s co-founder and telecommunications g...
Nov 18, 2021 (Gmt+09:00)
language -
Business & Politics
Samsung heir Lee on US trip for foundry investment, COVID vaccines
Jay Y. Lee, vice chairman and de facto leader of South Korea’s top conglomerate Samsung, has embarked on a business trip to North America to f...
Nov 14, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
Moderna co-founder
Giving away patents not in line with capitalist society
WASHINGTON D.C. -- US-based biotechnology company Moderna Inc. wasn’t a household name until the beginning of last year, when its fate changed...
Oct 12, 2021 (Gmt+09:00)
-
Asia’s Covid-19 Success Stories Warily Ponder Post-Vaccination Moves
Earlier this month, Singapore reached a Covid-19 milestone: The fully vaccinated portion of the population crossed 80%. But instead of moving ahead wi...
Sep 15, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience to kick off phase 3 vaccine trials
SK Bioscience Co. has received approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for phase 3 clinical trials of its COVID-19...
Aug 10, 2021 (Gmt+09:00)
language -
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
COVID treatment deals drive Samsung Bio’s record quarterly earnings
South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...
Jul 28, 2021 (Gmt+09:00)
-
Culture & Trends
Lee Kun-hee’s art collection exhibited from this month in Seoul
The lavish art collection donated by the Samsung Group following the death of group chairman Lee Kun-hee will be shown to the public from July 21. The...
Jul 20, 2021 (Gmt+09:00)
language -
COVID-19
Korea’s pharma consortium to develop mRNA vaccines by 2022
South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...
Jun 30, 2021 (Gmt+09:00)
language -
COVID-19
CureVac may pick Korea as Asian base for COVID vaccine production
German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...
Jun 16, 2021 (Gmt+09:00)
language -
Central bank
Bank of Korea governor sends stronger signal to raise rates this year
South Korea’s central bank governor on Friday flagged a tighter monetary policy for the second time in less than a month, fueling expectations...
Jun 11, 2021 (Gmt+09:00)
-
Korean stock market
Samsung returns as foreigners’ top pick; Kospi just shy of record high
Samsung Electronics Co., the bellwether of South Korea’s main bourse, has returned as the market darling, with foreigners buying heavily on th...
Jun 03, 2021 (Gmt+09:00)
language -
Airlines
Hanwha Aerospace in $320 mn deal to supply aircraft engine parts to GE
Hanwha Aerospace Co., a unit of South Korean conglomerate Hanwha Group, has won a $320 million deal to supply aircraft engine parts to General Elect...
May 25, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience secures up to $173.4 mn from CEPI for vaccine development
SK Bioscience Co. has secured additional funding for phase III clinical trial of GBP510, its COVID-19 vaccine candidate jointly developed with the I...
May 24, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics to make Moderna’s mRNA vaccine from Q3
Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...
May 23, 2021 (Gmt+09:00)
language -
COVID vaccines
Samsung Biologics in talks to produce Pfizer’s COVID-19 vaccine
South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...
May 12, 2021 (Gmt+09:00)
language -
COVID-19
Korean pharmas may turn into global vaccine makers on Biden remarks
South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...
May 07, 2021 (Gmt+09:00)
language -
COVID-19
Genexine exports COVID vaccine candidate to Indonesia
Genexine Inc., one of the five South Korean pharmaceutical companies whose COVID-19 vaccine candidates have entered clinical trials, will export its...
Apr 28, 2021 (Gmt+09:00)
language -
Korean stock market
Foreigners return to Korean market; Kosdaq at near 21-year high
Foreign investors, the dominant players on the Korean bourse, are returning as buyers of Samsung Electronics Co. and other blue chips, keeping the m...
Apr 12, 2021 (Gmt+09:00)
language -
Aerospace & Defense
S.Korea rolls out next-generation fighter jet KF-21 with local technology
South Korea on Friday unveiled a prototype of its homegrown fighter jet, the KF-21, two decades after it vowed to develop a next-generation superson...
Apr 09, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience halts flu vaccine output to focus on COVID vaccines
South Korea’s SK Bioscience Co. is suspending production of SKYCellflu, an influenza vaccine, to focus on manufacturing COVID-19 vaccines inst...
Mar 30, 2021 (Gmt+09:00)
language -
COVID-19
Green Cross in talks with Russia to produce COVID-19 vaccine
South Korea’s pharmaceutical company Green Cross Corporation (GC) is holding a series of close meetings on contract manufacturing of Russia&rs...
Mar 18, 2021 (Gmt+09:00)
language -
Pension funds
NPS may shed extra $21 bn in Korean stocks to cut exposure
The National Pension Service remains overexposed to South Korean stocks even after its 42-day consecutive net selling, and the world's third-largest...
Mar 02, 2021 (Gmt+09:00)
-
COVID-19
SK Bioscience eyes $900 mn annual sales from vaccine business
South Korea’s SK Bioscience Co. is looking to post 1 trillion won ($900 million) in annual revenue from its vaccine business as the biopharmac...
Feb 23, 2021 (Gmt+09:00)
language -
Celltrion eyes COVID-19 vaccine development
South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...
Feb 19, 2021 (Gmt+09:00)
language -
Economy
Korea’s treasury yields climb on hopes of vaccines, more bond issues
South Korea’s treasury yields are heading higher as advances in vaccine development and concerns over increased government bond sales prompt f...
Dec 20, 2020 (Gmt+09:00)